{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:50:56Z","timestamp":1791366656587,"version":"4.3.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Natural Science Foundation of Hunan Province, China","award":["2025JJ50597"],"award-info":[{"award-number":["2025JJ50597"]}]},{"name":"the Scientific Research Project of Hunan Provincial Health Commission in 2023","award":["D202301040025"],"award-info":[{"award-number":["D202301040025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06854-8","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:27:18Z","timestamp":1791318438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of molecular subtypes based on GATA3, KRT5, and P16 expression with clinicopathological features and prognosis in upper tract urothelial carcinoma"],"prefix":"10.1007","volume":"44","author":[{"given":"Jiayu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"1","key":"6854_CR1","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72(1):7\u201333","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"6854_CR2","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/bju.16620","volume":"135","author":"TA Axelsson","year":"2025","unstructured":"Axelsson TA, Syd\u00e9n F, Eisfeldt J, Eriksson Y, Lundberg GG, Jaremko G, Gyllensten OC, Tham E, Brehmer M (2025) Diagnostic and prognostic genomic aberrations in upper tract urothelial carcinoma can be identified in focal barbotage samples. BJU Int 135(5):792\u2013801","journal-title":"BJU Int"},{"issue":"21","key":"6854_CR3","doi-asserted-by":"publisher","first-page":"e70398","DOI":"10.1002\/cam4.70398","volume":"13","author":"S Wang","year":"2024","unstructured":"Wang S, Yan X, Lan W, Wang Y, Wang Z, Tong D, Zhang Y, Ran Q, Li H, Jin J et al (2024) Genetic Alterations in Chromatin Regulatory Genes in Upper Tract Urothelial Carcinoma and Urothelial Bladder Cancer. Cancer Med 13(21):e70398","journal-title":"Cancer Med"},{"issue":"1","key":"6854_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41419-025-08293-6","volume":"17","author":"G Li","year":"2025","unstructured":"Li G, Zhang E, Wang Z, Zhang Z, Zhang Y, Di S, Lu J, Cao S, Xie G, Zhang Y et al (2025) LncPEDS1-AS promotes UTUC resistance to lipid peroxidation by regulating PEDS1 expression via DDX23. Cell Death Dis 17(1):87","journal-title":"Cell Death Dis"},{"issue":"7","key":"6854_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076610","volume":"24","author":"F Sanguedolce","year":"2023","unstructured":"Sanguedolce F, Falagario UG, Zanelli M, Palicelli A, Zizzo M, Ascani S, Tortorella S, Mancini V, Cormio A, Carrieri G et al (2023) Clinicopathological features and survival analysis in molecular subtypes of muscle-invasive bladder cancer. Int J Mol Sci 24(7):6610","journal-title":"Int J Mol Sci"},{"issue":"11","key":"6854_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100300","volume":"36","author":"J Fontugne","year":"2023","unstructured":"Fontugne J, Xylinas E, Krucker C, Dixon V, Groeneveld CS, Pinar U, Califano G, Bucau M, Verine J, Desgrandchamps F et al (2023) Transcriptomic profiling of upper tract urothelial carcinoma: bladder cancer consensus classification relevance, molecular heterogeneity, and differential immune signatures. Mod Pathol 36(11):100300","journal-title":"Mod Pathol"},{"key":"6854_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147819","author":"F Sanguedolce","year":"2022","unstructured":"Sanguedolce F, Zanelli M, Palicelli A, Ascani S, Zizzo M, Cocco G, Bj\u00f6rnebo L, Lantz A, Falagario UG, Cormio L et al (2022) Are we ready to implement molecular subtyping of bladder cancer in clinical practice? Part 1: general issues and marker expression. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23147819","journal-title":"Int J Mol Sci"},{"issue":"7693","key":"6854_CR8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel EE III, Koeppen H, Astarita JL, Cubas R et al (2018) TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554(7693):544\u2013548","journal-title":"Nature"},{"issue":"1","key":"6854_CR9","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.1038\/s41467-020-18640-0","volume":"11","author":"A Taber","year":"2020","unstructured":"Taber A, Christensen E, Lamy P, Nordentoft I, Prip F, Lindskrog SV, Birkenkamp-Demtr\u00f6der K, Okholm TLH, Knudsen M, Pedersen JS et al (2020) Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis. Nat Commun 11(1):4858","journal-title":"Nat Commun"},{"issue":"5","key":"6854_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.eururo.2021.10.035","volume":"81","author":"G Sj\u00f6dahl","year":"2022","unstructured":"Sj\u00f6dahl G, Abrahamsson J, Holmsten K, Bernardo C, Chebil G, Eriksson P, Johansson I, Kollberg P, Lindh C, L\u00f6vgren K et al (2022) Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol 81(5):523\u2013532","journal-title":"Eur Urol"},{"issue":"1","key":"6854_CR11","doi-asserted-by":"publisher","first-page":"9743","DOI":"10.1038\/s41598-020-66747-7","volume":"10","author":"CC Guo","year":"2020","unstructured":"Guo CC, Bondaruk J, Yao H, Wang Z, Zhang L, Lee S, Lee JG, Cogdell D, Zhang M, Yang G et al (2020) Assessment of luminal and basal phenotypes in bladder cancer. Sci Rep 10(1):9743","journal-title":"Sci Rep"},{"issue":"2","key":"6854_CR12","first-page":"143","volume":"8","author":"CL Jackson","year":"2022","unstructured":"Jackson CL, Chen L, Hardy CS, Ren KY, Visram K, Bratti VF, Johnstone J, Sj\u00f6dahl G, Siemens DR, Gooding RJ et al (2022) Diagnostic and prognostic implications of a three-antibody molecular subtyping algorithm for non-muscle invasive bladder cancer. J Pathology: Clin Res 8(2):143\u2013154","journal-title":"J Pathology: Clin Res"},{"issue":"5","key":"6854_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1369\/00221554221095530","volume":"70","author":"CSC Hardy","year":"2022","unstructured":"Hardy CSC, Ghaedi H, Slotman A, Sj\u00f6dahl G, Gooding RJ, Berman DM, Jackson CL (2022) Immunohistochemical Assays for Bladder Cancer Molecular Subtyping: Optimizing Parsimony and Performance of Lund Taxonomy Classifiers. J Histochem Cytochem 70(5):357\u2013375","journal-title":"J Histochem Cytochem"},{"key":"6854_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.euros.2023.09.003","volume":"57","author":"C Hesswani","year":"2023","unstructured":"Hesswani C, Jackson CL, Marcq G, Hardy C, Kool R, Mansure JJ, Brimo F, Berman DM, Kassouf W (2023) Feasibility and Impact of Immunohistochemistry-based Molecular Subtyping for Muscle-invasive Bladder Cancer in Patients Treated with Radiation-based Therapy. Eur Urol Open Sci 57:22\u201329","journal-title":"Eur Urol Open Sci"},{"key":"6854_CR15","volume-title":"WHO Classification of Tumours: Urinary and Male Genital Tumours","author":"Board WHOCoTE","year":"2022","unstructured":"Board WHOCoTE (2022) WHO Classification of Tumours: Urinary and Male Genital Tumours, vol vol 8, 5th edn. International Agency for Research on Cancer, Lyon","edition":"5th edn"},{"issue":"1","key":"6854_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","volume":"79","author":"M Roupr\u00eat","year":"2021","unstructured":"Roupr\u00eat M, Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, Cowan NC, Dominguez-Escrig JL, Gontero P, Hugh Mostafid A et al (2021) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update. Eur Urol 79(1):62\u201379","journal-title":"Eur Urol"},{"issue":"2","key":"6854_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00428-022-03361-0","volume":"481","author":"FJ Queipo","year":"2022","unstructured":"Queipo FJ, Unamunzaga GM, Negro BF, Fuertes SG, Cort\u00e9s M, Tejedor EC, Ma\u00f1as CMB, Ari\u00f1o AB, Sj\u00f6dahl G, Beorlegui C (2022) Immunohistochemistry subtyping of urothelial carcinoma is feasible in the daily practice. Virchows Archiv: Int J Pathol 481(2):191\u2013200","journal-title":"Virchows Archiv: Int J Pathol"},{"key":"6854_CR18","unstructured":"Seethala RR, Algazi A, Cagle P, Carlson DL, Chute D, Faquin W, Hood K Jr, Pettus JSL, Richardson J (2017) MS : Template for Reporting Results of Biomarker Testing of Specimens from Patients with Tumours of the Head and Neck. In"},{"issue":"20","key":"6854_CR19","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","volume":"36","author":"AC Wolff","year":"2018","unstructured":"Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JMS, Bilous M, Ellis IO, Fitzgibbons P, Hanna W et al (2018) Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update. J Clin Oncol 36(20):2105\u20132122","journal-title":"J Clin Oncol"},{"issue":"8","key":"6854_CR20","doi-asserted-by":"publisher","first-page":"e617","DOI":"10.1093\/oncolo\/oyad070","volume":"28","author":"L Zhou","year":"2023","unstructured":"Zhou L, Shao Z, Liu Y, Yan X, Li J, Wu X, Tang B, Li S, Cui C, Chi Z et al (2023) HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population. Oncologist 28(8):e617\u2013e624","journal-title":"Oncologist"},{"issue":"5","key":"6854_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s00428-006-0150-4","volume":"448","author":"C Langner","year":"2006","unstructured":"Langner C, Hutterer G, Chromecki T, Rehak P, Zigeuner R (2006) Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract. Virchows Archiv: Int J Pathol 448(5):604\u2013611","journal-title":"Virchows Archiv: Int J Pathol"},{"issue":"1","key":"6854_CR22","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1097\/PAS.0000000000002053","volume":"48","author":"JI Warrick","year":"2024","unstructured":"Warrick JI, Al-Ahmadie H, Berman DM, Black PC, Flaig TW, H\u00f6glund M, Bubendorf L, van der Kwast TH, Cheng L (2024) International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer-Principles of Classification and Emerging Clinical Utility. Am J Surg Pathol 48(1):e32\u2013e42","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"6854_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/PAP.0000000000000430","volume":"31","author":"J Warrick","year":"2024","unstructured":"Warrick J (2024) Molecular Subtypes of Bladder Cancer: Component Signatures and Potential Value in Clinical Decision-making. Adv Anat Pathol 31(3):178\u2013187","journal-title":"Adv Anat Pathol"},{"issue":"11","key":"6854_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100300","volume":"36","author":"J Fontugne","year":"2023","unstructured":"Fontugne J, Xylinas E, Krucker C, Dixon V, Groeneveld CS, Pinar U, Califano G, Bucau M, Verine J, Desgrandchamps F et al (2023) Transcriptomic profiling of upper tract urothelial carcinoma: bladder cancer consensus classification relevance, molecular heterogeneity, and differential immune signatures. Mod Pathol 36(11):100300","journal-title":"Mod Pathol"},{"issue":"1","key":"6854_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semradonc.2022.10.001","volume":"33","author":"B Mau","year":"2023","unstructured":"Mau B, Johnson B, Hansel DE, McConkey DJ (2023) The many faces of muscle-invasive bladder cancer: histopathological and molecular characterization. Semin Radiat Oncol 33(1):1\u201311","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"6854_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/MOU.0000000000000943","volume":"32","author":"F Berndl","year":"2022","unstructured":"Berndl F, Hassler MR (2022) Molecular intricacies of upper tract urothelial carcinoma and their relevance for therapy considerations. Curr Opin Urol 32(1):48\u201353","journal-title":"Curr Opin Urol"},{"issue":"6","key":"6854_CR27","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.euo.2024.01.013","volume":"7","author":"K Shigeta","year":"2024","unstructured":"Shigeta K, Matsumoto K, Kitaoka S, Omura M, Umeda K, Arita Y, Mikami S, Fukumoto K, Yasumizu Y, Tanaka N et al (2024) Profiling fibroblast growth factor receptor 3 expression based on the immune microenvironment in upper tract urothelial carcinoma. Eur Urol Oncol 7(6):1338\u20131349","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"6854_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.annonc.2023.10.003","volume":"35","author":"AO Siefker-Radtke","year":"2024","unstructured":"Siefker-Radtke AO, Matsubara N, Park SH, Huddart RA, Burgess EF, \u00d6zg\u00fcro\u011flu M, Valderrama BP, Laguerre B, Basso U, Triantos S et al (2024) Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial. Ann Oncol 35(1):107\u2013117","journal-title":"Ann Oncol"},{"issue":"1","key":"6854_CR29","first-page":"89","volume":"35","author":"E Vlachou","year":"2025","unstructured":"Vlachou E, Hoffman-Censits J, Singla N (2025) The biologic landscape and therapeutic implications of upper tract urothelial cancer. Curr Opin Urol 35(1):89\u201395","journal-title":"Curr Opin Urol"},{"issue":"7","key":"6854_CR30","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1097\/00000478-200007000-00009","volume":"24","author":"RE Jimenez","year":"2000","unstructured":"Jimenez RE, Gheiler E, Oskanian P, Tiguert R, Sakr W, Wood DP Jr., Pontes JE, Grignon DJ (2000) Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol 24(7):980\u2013987","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"6854_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/2056-4538.12369","volume":"10","author":"M Angeloni","year":"2024","unstructured":"Angeloni M, van Doeveren T, Lindner S, Volland P, Schmelmer J, Foersch S, Matek C, Stoehr R, Geppert CI, Heers H et al (2024) A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testing. J Pathol Clin Res 10(2):e12369","journal-title":"J Pathol Clin Res"},{"issue":"4","key":"6854_CR32","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/JU.0000000000002799","volume":"208","author":"LM Nogueira","year":"2022","unstructured":"Nogueira LM, Yip W, Assel MJ, Tracey AT, Wong NC, Alvim RG, Al-Ahmadie H, Bajorin DF, Coleman JA (2022) Survival Impact of Variant Histology Diagnosis in Upper Tract Urothelial Carcinoma. J Urol 208(4):813\u2013820","journal-title":"J Urol"},{"issue":"11","key":"6854_CR33","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1007\/s00345-019-02678-x","volume":"37","author":"AM Aydin","year":"2019","unstructured":"Aydin AM, Singla N, Panwar V, Woldu SL, Freifeld Y, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M et al (2019) Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study. World J Urol 37(11):2419\u20132427","journal-title":"World J Urol"},{"issue":"6","key":"6854_CR34","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/cam4.432","volume":"4","author":"J Bellmunt","year":"2015","unstructured":"Bellmunt J, Werner L, Bamias A, Fay AP, Park RS, Riester M, Selvarajah S, Barletta JA, Berman DM, de Muga S et al (2015) HER2 as a target in invasive urothelial carcinoma. Cancer Med 4(6):844\u2013852","journal-title":"Cancer Med"},{"issue":"1","key":"6854_CR35","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00345-024-05222-8","volume":"42","author":"J Ye","year":"2024","unstructured":"Ye J, Chen Z, Liao X, Wang X, Zhang C, Han P, Wei Q, Bao Y (2024) HER2 expression in upper tract urothelial carcinoma and the relationship with clinicopathological characteristics-an analysis of 155 patients in Southwest China. World J Urol 42(1):521","journal-title":"World J Urol"},{"issue":"4","key":"6854_CR36","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00428-020-02951-0","volume":"478","author":"C Bontoux","year":"2021","unstructured":"Bontoux C, Rialland T, Cussenot O, Comp\u00e9rat E (2021) A four-antibody immunohistochemical panel can distinguish clinico-pathological clusters of urothelial carcinoma and reveals high concordance between primary tumor and lymph node metastases. Virchows Archiv: Int J Pathol 478(4):637\u2013645","journal-title":"Virchows Archiv: Int J Pathol"},{"issue":"4","key":"6854_CR37","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/ijc.33327","volume":"148","author":"T van Doeveren","year":"2021","unstructured":"van Doeveren T, Nakauma-Gonzalez JA, Mason AS, van Leenders G, Zuiverloon TCM, Zwarthoff EC, Meijssen IC, van der Made AC, van der Heijden AG, Hendricksen K et al (2021) The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder. Int J Cancer 148(4):981\u2013987","journal-title":"Int J Cancer"},{"issue":"2","key":"6854_CR38","doi-asserted-by":"publisher","first-page":"e12369","DOI":"10.1002\/2056-4538.12369","volume":"10","author":"M Angeloni","year":"2024","unstructured":"Angeloni M, van Doeveren T, Lindner S, Volland P, Schmelmer J, Foersch S, Matek C, Stoehr R, Geppert CI, Heers H et al (2024) A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testing. J Pathol Clin Res 10(2):e12369","journal-title":"J Pathol Clin Res"},{"key":"6854_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61050923","author":"N Kostakopoulos","year":"2025","unstructured":"Kostakopoulos N, Argyropoulos V, Bellos T, Katsimperis S, Kostakopoulos A (2025) Artificial intelligence and novel technologies for the diagnosis of upper tract urothelial carcinoma. Medicina (Kaunas, Lithuania). https:\/\/doi.org\/10.3390\/medicina61050923","journal-title":"Medicina (Kaunas, Lithuania)"},{"issue":"1","key":"6854_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6901","volume":"13","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Shi H, Fu S, Wang H, Wang J, Li X, Li Z, Hai B, Zhang J (2024) A computed tomography urography-based machine learning model for predicting preoperative pathological grade of upper urinary tract urothelial carcinoma. Cancer Med 13(1):e6901","journal-title":"Cancer Med"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06854-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06854-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06854-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:03:15Z","timestamp":1791363795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06854-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6854"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06854-8","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"12 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data in any form (including individual details, images, or videos).","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"733"}}